newsfilter
← Latest News
GlobeNewswire·

Adhera Therapeutics Appoints Dr. Andrew Reaume to Board of Directors

Baton Rouge, LA, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCPK: ATRX) ("Adhera" or the "Company"), a clinical stage biopharmaceutical company, is pleased to announce the appointment of Andrew G. Reaume, Ph.D., MBA to the Company's